Poly[(R )-3-hydroxybutyrate)]/poly(styrene) blends compatibilized with the relevant block copolymer

Enhanced ligand-free attachment of osteoblast to poly(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles

Polymeric nanoparticles have previously been used as substrates for cell attachment and proliferation due to their ability to mimic the extracellular matrix, but in general, they require surface chemical modifications to achieve this purpose. In this study, polymeric nanoparticles were developed and used without any matrix ligands functionalized on their surface to promote cell attachment and proliferation of human osteoblasts (MG63s). First, telechelic, reduced molar mass and diol-functionalized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) was prepared by transesterification using ethylene glycol. Then, PHBV-diol was used to prepare biodegradable nanoparticles via the solvent evaporation technique. MG63s were cultured in the presence of PHBV nanoparticles and growth kinetics were compared to that on tissue culture polystyrene (TCPS). Cell attachment on non-tissue culture polystyrene pre-coated with nanoparticles was assessed and compared to attachment on TCPS. The cell attachment study demonstrated that cells readily attached and were well spread onto the nanoparticle surfaces compared to non-tissue culture polystyrene. These findings reveal the potential of PHBV nanoparticles for cell attachment and growth to be used in tissue engineering.

Recent advances in the production of biomedical systems based on polyhydroxyalkanoates and exopolysaccharides

In recent years, growing attention has been devoted to naturally occurring biological macromolecules and their ensuing application in agriculture, cosmetics, food and pharmaceutical industries. They inherently have antigenicity, low immunogenicity, excellent biocompatibility and cytocompatibility, which are ideal properties for the design of biomedical devices, especially for the controlled delivery of active ingredients in the most diverse contexts. Furthermore, these properties can be modulated by chemical modification via the incorporation of other (macro)molecules in a random or controlled way, aiming at improving their functionality for each specific application. Among the wide variety of natural polymers, microbial polyhydroxyalkanoates (PHAs) and exopolysaccharides (EPS) are often considered for the development of original biomaterials due to their unique physicochemical and biological features. Here, we aim to fullfil a gap on the present associated literature, bringing an up-to-date overview of ongoing research strategies that make use of PHAs (poly (3-hydroxybutyrate), poly (3-hydroxybutyrate-co-3-hydroxyvalerate), poly (3-hydroxyoctanoate), poly(3-hydroxypropionate), poly (3-hydroxyhexanoate-co-3-hydroxyoctanoate), and poly (3-hydroxybutyrate-co-3-hydroxyhexanoate)) and EPS (bacterial cellulose, alginates, curdlan, pullulan, xanthan gum, dextran, hyaluronan, and schizophyllan) as sources of interesting and versatile biomaterials. For the first time, a monograph addressing the properties, pros and cons, status, challenges, and recent progresses regarding the application of these two important classes of biopolymers in biomedicine is presented.

Bio- and Fossil-Based Polymeric Blends and Nanocomposites for Packaging: Structure⁻Property Relationship

In the present review, the possibilities for blending of commodities and bio-based and/or biodegradable polymers for packaging purposes has been considered, limiting the analysis to this class of materials without considering blends where both components have a bio-based composition or origin. The production of blends with synthetic polymeric materials is among the strategies to modulate the main characteristics of biodegradable polymeric materials, altering disintegrability rates and decreasing the final cost of different products. Special emphasis has been given to blends functional behavior in the frame of packaging application (compostability, gas/water/light barrier properties, migration, antioxidant performance). In addition, to better analyze the presence of nanosized ingredients on the overall behavior of a nanocomposite system composed of synthetic polymers, combined with biodegradable and/or bio-based plastics, the nature and effect of the inclusion of bio-based nanofillers has been investigated.

Controlling injectability and in vivo stability of thermogelling copolymers for delivery of yttrium-90 through intra-tumoral injection for potential brachytherapy

Intra-tumoral injection of radiopharmaceuticals such as yttrium-90 (⁹⁰Y) or phosphorus-32 (³²P) is an important route for brachytherapy in unresectable solid tumors such as locally advanced hepatocellular carcinoma. However, the injected radiopharmaceuticals can potentially leak out from the tumor site due to high intra-tumoral pressure. In this study, we demonstrated the use of thermogelling copolymers that can be injected into tumor and subsequently solidify as hydrogels within the tumor that can potentially overcome the above problem. To this end, a series of thermogelling polyurethane copolymers with varying compositions were designed and synthesized from Pluronic F127, poly(3-hydroxylbutyrate), and poly(propylene glycol), which were characterized in terms of their molecular structures, compositions, phase diagrams, rheological properties, and injectability and body temperature stability in vitro and in vivo. The analyses of our data elucidated the injectability of the copolymer solutions at low temperatures, and the stability of the hydrogels at the body temperature. This provided the basis on which we could identify one copolymer with balanced composition as the most suitable candidate for intra-tumoral injection and for prevention of the leakage. Finally, the injectability and in vivo stability of the copolymer solution and hydrogel loaded with ⁹⁰Y were further demonstrated in a mouse tumor model, and the in vivo biodistribution of ⁹⁰Y showed that the radionuclide could be retained at the tumor site, indicating that the ⁹⁰Y-loaded copolymer has a great potential for tumor radio-brachytherapy.

Polyhydroxybutyrate (PHB)-based triblock copolymers: synthesis of hydrophobic PHB/poly(benzyl β-malolactonate) and amphiphilic PHB/poly(malic acid) analogues by ring-opening polymerization

Poly(benzyl β-malolactonate)-b-poly(3-hydroxybutyrate)-b-poly(benzyl β-malolactonate), PMLA^Be-b-PHB-b-PMLA^Be, and its analogous poly(β-malic acid), PMLA-b-PHB-b-PMLA, triblock copolymers are synthesized and fully characterized.

The Synthesis of Poly-β-Hydroxybutyrate by Moderately Halophilic Bacteria Halomonas venusta

In this study, poly-β-hydroxybutyrate (PHB) was synthesized by moderately halophilic bacteria Halomonas venusta and identified by 1H-NMR. The effects of different carbon sources, salt concentration, initial carbon nitrogen quality ratio, initial phosphate concentration were studied on the synthesis of PHB. The optimum conditions of the PHB synthesis were detemined. Glucose was as carbon source with the concentration of 80 g/L and salt concentration, initial carbon nitrogen ratio, initial phosphate concentration was 3%, 15 and 1.9 g/L respectively. Under the above conditions, a two-phase synthesis system of PHB was constructed. The PHB synthesis amount and yield of cell dry weight was reached up to 1.5 g/L and 69.19 wt.%, respectively. The efficient synthesis of PHB was realized.